Martyn Jacobs

Stock Analyst at Bell Potter

(0.05)
# 4,868
Out of 5,134 analysts
223
Total ratings
16.9%
Success rate
-19.3%
Average return

Stocks Rated by Martyn Jacobs

Artrya Limited
Nov 15, 2026
Reiterated: Buy
Price Target: $4.30 → $5.20
Current: $3.17
Upside: +64.30%
EBR Systems, Inc.
Nov 10, 2026
Reiterated: Buy
Price Target: $0.20 → $0.30
Current: $0.16
Upside: +93.55%
Pharmx Technologies Limited
Nov 10, 2026
Reiterated: Buy
Price Target: $0.20
Current: $0.07
Upside: +198.51%
Lumos Diagnostics Holdings Limited
Nov 9, 2026
Reiterated: Buy
Price Target: $0.20
Current: $0.07
Upside: +185.71%
ImpediMed Limited
Nov 1, 2026
Reiterated: Buy
Price Target: $0.01
Current: $0.00
Upside: +150.00%
Integral Diagnostics Limited
Oct 29, 2026
Reiterated: Buy
Price Target: $3.15 → $2.70
Current: $1.66
Upside: +62.65%
Vitrafy Life Sciences Limited
Oct 29, 2026
Reiterated: Buy
Price Target: $5.15 → $4.85
Current: $2.40
Upside: +102.08%
Oneview Healthcare PLC
Oct 27, 2026
Reiterated: Buy
Price Target: $0.42 → $0.30
Current: $0.14
Upside: +114.29%
Biome Australia Limited
Oct 26, 2026
Reiterated: Buy
Price Target: $0.75
Current: $0.37
Upside: +102.70%
EMVision Medical Devices Ltd
Oct 26, 2026
Reiterated: Buy
Price Target: $3.15
Current: $1.43
Upside: +121.05%
Reiterated: Buy
Price Target: $0.45 → $0.50
Current: $0.28
Upside: +81.82%
Reiterated: Buy
Price Target: $1.00
Current: $0.43
Upside: +132.56%
Reiterated: Hold
Price Target: $0.77 → $0.75
Current: $0.75
Upside: -
Reiterated: Buy
Price Target: $0.75 → $0.50
Current: $0.26
Upside: +92.31%
Reiterated: Buy
Price Target: $28.75 → $27.50
Current: $19.84
Upside: +38.64%
Rated: Hold
Price Target: n/a
Current: $0.008
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.012
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.036
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $3.30
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $2.83
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.069
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.045
Upside: n/a